---
title: "Liability-threshold rare-variant test (LTBT) links HTRA3 to idiopathic pulmonary fibrosis"
id: "medrxiv-9-a-new-liability-based-rare-variant-burden-test-identifies-a-novel-genetic"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-9-a-new-liability-based-rare-variant-burden-test-identifies-a-novel-genetic"
content_type: "clinical_feed_article"
specialty: "Pulmonology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.17.26368326v1?rss=1"
published_at: "2026-11-19T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Liability-threshold rare-variant test (LTBT) links HTRA3 to idiopathic pulmonary fibrosis
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-9-a-new-liability-based-rare-variant-burden-test-identifies-a-novel-genetic
- **Specialty:** [Pulmonology](https://medichelpline.com/clinical-feed/pulmonology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.17.26368326v1?rss=1)
- **Published At:** 2026-11-19T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators developed a novel rare-variant association test for binary traits termed the **liability threshold burden test (LTBT)**, which jointly models rare variants and polygenic risk scores (PRS) under a liability threshold framework. - The study team reported that LTBT controlled the false positive rate in simulated datasets and improved sensitivity compared with existing burden tests in those simulations. - For binary traits, previous PRS-adjusted rare-variant approaches showed limited or no power gain; authors designed LTBT to address that shortfall by modeling the genetic background explicitly as liability. - The authors applied LTBT to sequencing datasets for **idiopathic pulmonary fibrosis (IPF)** and accounted for individual genetic background with a **PRS** covariate. - Using LTBT, the cohort showed a novel, significant association between rare predicted damaging missense variants in **HTRA3** (HtrA serine peptidase 3) and IPF; this association was reported as replicated in an independent dataset by the study team. - The preprint reports IRB approval from Mass General Brigham (#2016P000837) and notes that all necessary consents were obtained. - Data are available on reasonable request and the authors provided software at https://github.com/sgchun/ltbt. - The manuscript is a medRxiv preprint and has not undergone peer review; the authors declared no competing interests. - Funding sources listed include NIH grants (R56HL171620, R01HL111024, R01HL135142, R01HL130974).
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=bWL2VEmlbN76SDVOKHDDH5j7JrjHm2EtjLbzJnudJLQ-1795144148.3348799-1.2.1.1-hZUfFTwIes1TiUWxPGao1Mr.JCPoB9_8nM7j0EIKhiaYV3peKoUrpvNJDKJHGtqQ) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.17.26368326v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # A new liability-based rare-variant burden test identifies a novel genetic association between HTRA3 and idiopathic pulmonary fibrosis [ View ORCID Profile](http://orcid.org/0000-0003-3440-1913)Sung Chun, Ahmad Samiei, Lauren Flynn, Heidi Makrynioti, Matthew Moll, Anna L Peljto, David A Schwartz, Michael H Cho, Shamil R Sunyaev, Ivan O Rosas, Gary M Hunninghake, Benjamin A Raby doi: https://doi.org/10.64898/2026.11.17.26368326 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Sung Chun 1 Boston Children's Hospital; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sung%2BChun%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Chun%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ASung%2BChun%2B) * [ORCID record for Sung Chun](http://orcid.org/0000-0003-3440-1913 "Open in new tab") * For correspondence: sung.g.chun@gmail.com Ahmad Samiei 1 Boston Children's Hospital; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ahmad%2BSamiei%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Samiei%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAhmad%2BSamiei%2B) Lauren Flynn 1 Boston Children's Hospital; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lauren%2BFlynn%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Flynn%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALauren%2BFlynn%2B) Heidi Makrynioti 1 Boston Children's Hospital; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Heidi%2BMakrynioti%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Makrynioti%20H&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHeidi%2BMakrynioti%2B) Matthew Moll 2 Channing Division of Network Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Matthew%2BMoll%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Moll%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMatthew%2BMoll%2B) Anna L Peljto 3 University of Colorado, Aurora; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Anna%2BL%2BPeljto%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Peljto%20AL&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAnna%2BL%2BPeljto%2B) David A Schwartz 3 University of Colorado, Aurora; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=David%2BA%2BSchwartz%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Schwartz%20DA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADavid%2BA%2BSchwartz%2B) Michael H Cho 2 Channing Division of Network Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Michael%2BH%2BCho%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Cho%20MH&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMichael%2BH%2BCho%2B) Shamil R Sunyaev 4 Harvard Medical School; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Shamil%2BR%2BSunyaev%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sunyaev%20SR&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AShamil%2BR%2BSunyaev%2B) Ivan O Rosas 5 Baylor College of Medicine; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ivan%2BO%2BRosas%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Rosas%20IO&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AIvan%2BO%2BRosas%2B) Gary M Hunninghake 6 Brigham and Women's Hospital * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Gary%2BM%2BHunninghake%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hunninghake%20GM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AGary%2BM%2BHunninghake%2B) Benjamin A Raby 1 Boston Children's Hospital; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Benjamin%2BA%2BRaby%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Raby%20BA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABenjamin%2BA%2BRaby%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.17.26368326v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1349192/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.17.26368326v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1349192/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.17.26368326v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1349192/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.17.26368326v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1349192/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.17.26368326v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1349192/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract In contrast to large-effect monogenic variants, which are highly penetrant regardless of genetic background, variants with more modest effect sizes depend on a carrier's genetic background to manifest disease. For many complex traits, including idiopathic pulmonary fibrosis (IPF), polygenic risk scores (PRS) have been shown to capture a significant proportion of the genetic background risk. While a rare-variant association test incorporating a PRS covariate to account for the genetic background has been demonstrated to improve statistical power for gene discovery in quantitative traits, for binary traits, this approach shows limited or no power gain over PRS-unadjusted tests. Here, we propose a novel rare-variant association test for binary traits that jointly models the contribution of rare variants and PRS under a liability threshold model. In simulated datasets, our new method, liability threshold burden test (LTBT), shows a well-controlled false positive rate and outperforms the sensitivity of existing methods. To demonstrate this new method, we apply it to sequencing datasets for IPF, a rare but highly morbid lung disease. By accounting for an individual's genetic background with PRS, we identify and formally replicate a significant novel association of rare predicted damaging missense variants in HTRA3 (HtrA serine peptidase 3) with IPF. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The IRB of Mass General Brigham gave approval for this work (#2016P000837). I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the authors. Software developed for this study is available online at https://github.com/sgchun/ltbt. ## Funder Information Declared NIH, R56HL171620, R01HL111024, R01HL135142, R01HL130974 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC-ND 4.0 International license](http://creativecommons.org/licenses/by-nc-nd/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.17.26368326v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.17.26368304v1 "WakeSentry: real-time awakening detection from single-channel EEG across sleep cohorts and forehead headbands")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.17.26368300v1 "The Shrinking Grace Period and the Downsizing of Ransomware Victims: Exploitation Timelines and Breach Size Among US Health Care Providers, 2016-2026") Posted November 19, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.17.26368326v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/19/2026.11.17.26368326.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.17.26368326v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/19/2026.11.17.26368326.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) A new liability-based rare-variant burden test identifies a novel genetic association between HTRA3 and idiopathic pulmonary fibrosis Sung Chun, Ahmad Samiei, Lauren Flynn, Heidi Makrynioti, Matthew Moll, Anna L Peljto, David A Schwartz, Michael H Cho, Shamil R Sunyaev, Ivan O Rosas, Gary M Hunninghake, Benjamin A Raby medRxiv 2026.11.17.26368326; doi: https://doi.org/10.64898/2026.11.17.26368326 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368326v1%26text%3DA%2520new%2520liability-based%2520rare-variant%2520burden%2520test%2520identifies%2520a%2520novel%2520genetic%2520association%2520between%2520HTRA3%2520and%2520idiopathic%2520pulmonary%2520fibrosis "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368326v1%26t%3DA%2520new%2520liability-based%2520rare-variant%2520burden%2520test%2520identifies%2520a%2520novel%2520genetic%2520association%2520between%2520HTRA3%2520and%2520idiopathic%2520pulmonary%2520fibrosis "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368326v1%26title%3DA%2520new%2520liability-based%2520rare-variant%2520burden%2520test%2520identifies%2520a%2520novel%2520genetic%2520association%2520between%2520HTRA3%2520and%2520idiopathic%2520pulmonary%2520fibrosis%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.17.26368326v1%26title%3DA%2520new%2520liability-based%2520rare-variant%2520burden%2520test%2520identifies%2520a%2520novel%2520genetic%2520association%2520between%2520HTRA3%2520and%2520idiopathic%2520pulmonary%2520fibrosis "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.17.26368326) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (642) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (926) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (355) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5051) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (432) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (681) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1703) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16336) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (37) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1248) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7320) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (758) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1100) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5337) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1480) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1846) * [Hematology](https://www.medrxiv.org/collection/hematology) (602) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1388) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16533) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1208) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (702) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (157) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (755) * [Neurology](https://www.medrxiv.org/collection/neurology) (7654) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1140) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1303) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1045) * [Oncology](https://www.medrxiv.org/collection/oncology) (3763) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1104) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (413) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (472) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (506) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (144) * [Pathology](https://www.medrxiv.org/collection/pathology) (725) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1875) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacolog
## Related Clinical Research

- [Circadian Rhythms Modulate Biologic Targets in Asthma: Transcriptome Analysis](https://medichelpline.com/clinical-feed/medrxiv-1-timing-the-target-exploring-the-circadian-transcriptome-of-biologic-therapies.md)
- [High blood pressure in Ugandan children and adolescents with Type 1 diabetes: multicenter prevalen](https://medichelpline.com/clinical-feed/plos-one-11-high-blood-pressure-among-children-and-adolescents-with-type-1-diabetes.md)
- [Triglyceride-Glucose Index Linked to Airflow Limitation Severity in Older Nondiabetic, Normoxemic](https://medichelpline.com/clinical-feed/pubmed-43067697.md) (DOI: 10.12659/MSM.954698)
- [Allergens in glucose monitoring systems identified by validated GC-MS; evidence of a 'sponge effec](https://medichelpline.com/clinical-feed/pubmed-42887950.md) (DOI: 10.1016/j.aca.2026.346179)
- [Leveraging MAHA and Kennedy to Combat Measles Vaccine Hesitancy](https://medichelpline.com/clinical-feed/stat-news-0-opinion-how-kennedy-and-maha-could-help-stop-measles.md)

## Navigation
- [← Back to Pulmonology Feed](https://medichelpline.com/clinical-feed/pulmonology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.